06/02/2026
Recent commercial procedures by Dr. Neal Patel and Dr. Jason Lomboy of Advanced Urology mark the continued adoption of the Vanquish® Water V***r Ablation System in routine clinical practice.
These cases reflect the expanding use of a minimally invasive approach for targeted prostate tissue ablation.
“Early clinical data from the V***R 2 study suggests that this approach can deliver meaningful prostate tissue ablation with a favorable safety profile,” added Dr. Lomboy also of Advanced Urology. “Patients have reported minimal discomfort and high satisfaction following their procedure, reinforcing our confidence in adding this technology to our minimally invasive options in prostate care as we continue to evaluate longer-term outcomes.”
Developed by Francis Medical, the Vanquish System delivers high-energy sterile water v***r via a transurethral approach to ablate targeted prostate tissue.
Read more in the press release: www.francismedical.com/news
Rx Only. FDA Cleared. See francismedical.com for safety information.